RxDoctor Payments Data

Dirk Beyer

Optometrist · Hamilton, MTNPI 1699722249

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,250 of the $3,504 with a category attached, or 64.2%. Alcon accounts for 85.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,821 and has fallen 99.0% since, to $18 in 2025. Among optometrist clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,504in general payments, 2019–2025

Across 31 payments — averaging $113.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Glaukos Corporation$151
  • Astellas Pharma US Inc$120
  • Coopervision Inc.$96
  • Optos, Inc.$74
  • AbbVie$36
  • plus $18 from 1 others

What the payments were for

  • Speaking & faculty fees$2,25064%
  • Food & beverage$1,18034%
  • Entertainment$742%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,504 in reported general payments places this provider in the 95th percentile of 184 optometrist providers in Montana.

See all optometrist providers in Montana

Medicare billing

Part B allowed, 2024
$99,422
Medicare patients
515
Services billed
1,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Loteprednol Etabonate13$1,641
Latanoprost85$1,259
Tobramycin-DexamethasoneTobramycin/Dexamethasone25$848
Travoprost11$477
ErythromycinErythromycin Base12$163
Brimonidine Tartrate12$68
Timolol Maleate14$58

Paid to pharmacies, not to this prescriber.

Other optometrist in Hamilton

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →